SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
NASDAQ:AKTS

Akoustis Technologies - AKTS Stock Forecast, Price & News

$2.83
-0.13 (-4.39%)
(As of 10/7/2022 05:28 PM ET)
Add
Compare
Today's Range
$2.79
$2.91
50-Day Range
$2.84
$5.23
52-Week Range
$2.77
$9.10
Volume
286,118 shs
Average Volume
494,824 shs
Market Capitalization
$161.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Akoustis Technologies MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
214.7% Upside
$9.00 Price Target
Short Interest
Bearish
9.24% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$111,688 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.71) to ($0.46) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Computer And Technology Sector

509th out of 633 stocks

Telephone & Telegraph Apparatus Industry

7th out of 10 stocks

AKTS stock logo

About Akoustis Technologies (NASDAQ:AKTS) Stock

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industry in the United States, Asia, Europe, and internationally. It operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services and microelectromechanical systems foundry services. The RF Filters segment sells amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense applications. Akoustis Technologies, Inc. is headquartered in Huntersville, North Carolina.

Receive AKTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoustis Technologies and its competitors with MarketBeat's FREE daily newsletter.

AKTS Stock News Headlines

Akoustis Technologies FQ3 2022 Earnings Preview
AKTS Jun 2022 12.500 call
Akoustis Technologies names Ken Boller as CFO
Akoustis Appoints Ken Boller as Chief Financial Officer
Akoustis Technologies Q2 2022 Earnings Preview
See More Headlines
Receive AKTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoustis Technologies and its competitors with MarketBeat's FREE daily newsletter.

AKTS Company Calendar

Last Earnings
10/31/2021
Today
10/07/2022
Next Earnings (Estimated)
11/07/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Telephone & telegraph apparatus
Sub-Industry
N/A
Current Symbol
NASDAQ:AKTS
Fax
N/A
Employees
156
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.00
High Stock Price Forecast
$13.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+218.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-59,030,000.00
Net Margins
-384.62%
Pretax Margin
-397.57%

Debt

Sales & Book Value

Annual Sales
$15.35 million
Book Value
$1.85 per share

Miscellaneous

Free Float
54,138,000
Market Cap
$161.96 million
Optionable
Not Optionable
Beta
1.55

Key Executives

  • Mr. Jeffrey B. ShealyMr. Jeffrey B. Shealy (Age 53)
    Founder, Pres, CEO & Director
    Comp: $734.72k
  • Mr. David M. AicheleMr. David M. Aichele (Age 56)
    Exec. VP of Bus. Devel.
    Comp: $325.02k
  • Mr. Kenneth E. BollerMr. Kenneth E. Boller (Age 50)
    CFO & Corp. Controller
  • Mr. Andrew Wright
    Gen. Counsel & Corp. Sec.
  • Ms. Mary Winters
    Exec. VP of Fab & Corp. Operations
  • Mr. Kamran Cheema
    Chief Product Officer













AKTS Stock - Frequently Asked Questions

Should I buy or sell Akoustis Technologies stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AKTS shares.
View AKTS analyst ratings
or view top-rated stocks.

What is Akoustis Technologies' stock price forecast for 2022?

2 Wall Street analysts have issued twelve-month price objectives for Akoustis Technologies' shares. Their AKTS share price forecasts range from $5.00 to $13.00. On average, they expect the company's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 218.0% from the stock's current price.
View analysts price targets for AKTS
or view top-rated stocks among Wall Street analysts.

How have AKTS shares performed in 2022?

Akoustis Technologies' stock was trading at $6.68 at the beginning of 2022. Since then, AKTS stock has decreased by 57.6% and is now trading at $2.83.
View the best growth stocks for 2022 here
.

When is Akoustis Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our AKTS earnings forecast
.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies, Inc. (NASDAQ:AKTS) issued its quarterly earnings data on Sunday, October, 31st. The technology company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by $0.05. The technology company earned $1.87 million during the quarter, compared to the consensus estimate of $1.97 million. Akoustis Technologies had a negative trailing twelve-month return on equity of 43.81% and a negative net margin of 384.62%. The firm's revenue for the quarter was up 192.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.23) EPS.

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Block (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

How do I buy shares of Akoustis Technologies?

Shares of AKTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $2.83.

How much money does Akoustis Technologies make?

Akoustis Technologies (NASDAQ:AKTS) has a market capitalization of $161.96 million and generates $15.35 million in revenue each year. The technology company earns $-59,030,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis.

How many employees does Akoustis Technologies have?

The company employs 156 workers across the globe.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The official website for the company is www.akoustis.com. The technology company can be reached via phone at (704) 997-5735 or via email at bprag@delmarconsulting.com.

This page (NASDAQ:AKTS) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.